Aljian Capital Management LLC Increases Position in UnitedHealth Group Incorporated (NYSE:UNH)

Aljian Capital Management LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,243 shares of the healthcare conglomerate's stock after acquiring an additional 2,017 shares during the quarter. UnitedHealth Group comprises approximately 2.2% of Aljian Capital Management LLC's portfolio, making the stock its 9th biggest position. Aljian Capital Management LLC's holdings in UnitedHealth Group were worth $9,497,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. International Assets Investment Management LLC increased its holdings in shares of UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock valued at $3,096,896,000 after acquiring an additional 5,290,025 shares during the last quarter. Swedbank AB acquired a new stake in shares of UnitedHealth Group during the first quarter valued at about $1,117,462,000. Lone Pine Capital LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter worth approximately $480,903,000. Dimensional Fund Advisors LP boosted its stake in UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate's stock valued at $1,942,956,000 after purchasing an additional 880,183 shares during the period. Finally, Baillie Gifford & Co. increased its position in UnitedHealth Group by 1,125.4% in the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate's stock valued at $455,281,000 after acquiring an additional 821,050 shares during the period. Institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

UNH has been the subject of several recent research reports. Hsbc Global Res cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Thursday, October 17th. Truist Financial reaffirmed a "buy" rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Stephens decreased their target price on UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating for the company in a research report on Wednesday, October 16th. Cantor Fitzgerald increased their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an "overweight" rating in a report on Wednesday, October 16th. Finally, Royal Bank of Canada dropped their price objective on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a research note on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average target price of $615.53.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $2.58 during midday trading on Monday, reaching $589.65. 2,577,075 shares of the company's stock traded hands, compared to its average volume of 3,883,119. The company has a market cap of $542.64 billion, a P/E ratio of 38.41, a PEG ratio of 1.74 and a beta of 0.58. The company has a fifty day simple moving average of $582.75 and a two-hundred day simple moving average of $550.66. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to analysts' expectations of $99.14 billion. During the same period in the previous year, the business posted $6.56 earnings per share. UnitedHealth Group's quarterly revenue was up 9.2% on a year-over-year basis. Equities analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.